Радионуклидная диагностика для практических врачей - Лишманова Ю.Б.
ISBN 5-93629-166-9
Скачать (прямая ссылка):
76. Gill J.B., Ruddy TD. et al. Prognostic importance of thallium uptake by the lungs during exercise in coronary artery disease// N. Engl. J. Med. -1987. - Vol. 317. - P. 1485-1489.
77. Grames G.M., Jansen С, Gander M.P. et al. Safety of the direct coronary injection of radiolabeled particles //J. Nucl. Med. - 1974. - Vol. 15. -P. 2.
78. Grunwald A.M., Watson D.D., Holzgrefe H.H. Myocardial thallium-201 kinetics in normal and ischemic myocardium // Circulation. - 1981. -Vol. 64. - P. 610-18.
79. Guiney Т.Е., Pohost G.M., McKusick K,A. Differentiation of false- from true-positive ECG responses to exercise stress by thallium-201 perfusion imaging // Chest. - 1981. - Vol. 80. - P. 4-10.
80. Hamilton G.W., Trobaugh G.B., Ritchie J.L. Myocardial imaging with intravenously injected thallium-201 in patients with suspectid coronary disease: Analisis of technique and correlation with electrocardiographic, coronary and ventriculographic findings // Am. J. Cardiol. - 1977. -Vol. 39. - P. 347-54.
81. Hamilton G.W., Narachara K.A., Jee H. Myocardial imaging with Thallium-201: effect of cardiac drugs on myocardial imaging and absolute tissue distribution//J. Nucl. Med. - 1978.-Vol. 19. - P. 10-6.
82. Hamm C.W. Radiologic methods in cases of coronary heart disease: diagnostic requirements from the cardiology point of view // Rontgenblatter. - 1990.-Vol. 3(9).-P. 367-9.
83. Harris D.N.E The use of dipyridamole with myocardial imaging. - MD Thesis, Bristol University, UK, 1982.
84. Higley B., Smith F.W., Smith T. et al. Technetium-99m-l,2-bis [bis(2-ethoxyethyl) phosphinol ethane. Human biodistribution, dosimetry and safety of a new myocardial perfusion imaging agent //J. Nucl. Med. - 1993. - Vol. 34. - P. 30-8.
85. Holman B.L. Myocardial infarct imaging // Am. J. Cardiol. - 1982. - Vol. 49 (5). - P. 1347-54.
86. Holman B.L. Radionuclide methods in the evaluation of myocardial ischemia and infarction // Circulation. - 1976. - Vol. 53 (3) (Supp. 1). -P. 1112-9.
87. Holman B.L., Janes A.G., Lister-James J. cet al. A newTc-99m-labelled myocardial imaging agent, hexakis (t-butylisonitrile) technetium (1) [Tc-99m TBI]: Initial experience in the human // J. Nucl. Med. - 1984. - Vol. 25. - P. 1350-5.
88. Holmberg 5., Serllysko W., Varnauskas E. Coronary circulation during heavy exercise in control subjects and patients with coronary heart disease//Acta. Med. Scand. - 1971. - Vol. 190. - P. 465-80.
89. Hor J., Sebening H., Sauer F TI-201 redestribution in coronary heart disease: early and delayed myocardial scans // J. Nucl. Med. - 1977. -Vol. 18. - P. 599.
90. Hurwitz G.A., Fox S.P., Driedger A.A. et al. Pulmonary uptake of sestamibi on early post-stress images: angiographyc relationships, incidence and kinetics // Nucl. Med. Comm. - 1993. - Vol. 14. - P. 15-22.
91. Hurwitz G.A., O'Donoghue J.P., Powe J.E. Pulmonary thallium-201 uptake following dipyridamole-exercise combination compared with single modality stress testing // Amer. J. Cardiol. - 1992. - Vol. 69 (4). - P. 320-6.
92. Ilmer В., Reijs A.E., Fioretti P. C et al. Comparative study of three different approaches on the estimation of the lung-heart ratio in thallium 201 scintigrams in relation to the extent of coronary artery disease and left ventricular function // Eur. J. Nucl. Med. - 1991. - Vol. 18 (4). - P. 252-8.
93. Iskandrian A.S., Hakki A.H. et al. Prognostic implications of exercise thallium-201 scintigraphy in patients with suspected or known coronary artery disease //Am. Heart J. - 1985. - Vol. 110. - P. 135-143.
94. Iskandrian A.S., Hakki A.H. Radionuclide evaluation of exercise left ventricular performance in patients with coronary artery disease//Am. Heart J.- 1985.-Vol. 110(4).-P. 851-6.
95. Iskandrian A.S., Hakki A.N. Thallium-201 myocardial scintigraphy//Am. Heart J. - 1985. - Vol. 109 (1). - P. 113-29.
96. Iskandrian A.S., Heo J et al. Use of exercise thallium-201 imaging for risk stratification of elderly patients with coronary artery disease // Am. J. Cardiol. - 1988. - Vol. 61. - P. 269-272.
97. Iskandrian A.S., Segal B.L. Value of exercise thallium-201 imagning in patients with diagnostic and nondiagnostic electrocardiograms // Amer. J. Cardiol. - 1981. - Vol. 48 (2). - P. 233.
98. Iskandrian A.S., Chae S.C., Heo J., Stanberry CD., Waaserleben V, Cave V. Independent and incremental prognostic value of single photon emission computed tomographic (SPECT) thallium imaging in coronary artery disease // Am. Coll. Cardiol. - 1993. - Vol. 22. - P. 665-70.
99. Jancen C1 Judkins M.P., Grames G.M. et al. Myocardial perfusion color scintigraphy with MAA// Radiology. - 1973. - Vol. 109. - P. 369.
100. Johnson L.L. Clinical Experience with technetium-99m leboroxime//Semin. Nucl. Med. - 1991. - Vol. 21. - P. 182-9.
101. Johnson L.L., Seldin D.W. Clinical experience with technetium-99mTeboroxime, a neutral, lipophilic myocardial perfusion imaging agent//Amer. J. Cardiol. - 1990. - Vol. 66 (13). - P. 63-7.
102. Kahn J.K., Mc-Ghielain. Quantitative rotational tomography with 201Tl and 99mTc-2-methoxy-isobutyl-isonitrile. A direct comparison in normal individuals and patients with coronary artery disease // Circulation. - 1989. - Vol. 79 (6). - P. 1282-93.
